Department of Veterans Affairs Awarded a Contract to AMERICAN NATIONAL RED CROSS, THE for $256,494.72

Summary of Award

The awarded contract under review is identified by the unique award ID "CONT_IDV_36C26024D0019_3600" and pertains to a category of contracts known as Indefinite Delivery/Indefinite Quantity (IDV), specifically classified under IDV_B_B. This type of contract allows for the negotiation of particular terms for each order, providing flexibility and practicality when precise quantities or time frames cannot be predetermined. The contract was signed on February 28, 2024, with a potential scope of $256,494.72, outlining the service description as "Therapeutic Apheresis." This medical process involves the removal or exchange of substances from a donor's blood, emphasizing the nature of specialized medical support at the heart of this agreement.

The recipient of this contract is the American National Red Cross, headquartered in Washington, D.C. The organization is well-regarded for its medical and humanitarian services, encompassing health emergencies and disaster relief. Within the context of this contract, the Red Cross is set to provide specialized medical services in alignment with their operational competencies, falling under the NAICS code 621991, which designates entities dealing in "Blood and Organ Banks." This classification elucidates the nature of services anticipated, suggesting a focus on blood-related medical support and transactional services.

The Department of Veterans Affairs (VA) is both funding and awarding this contract, specifically through its Network Contract Office 20, located in Portland. The engagement of the VA underscores a strategic alignment with their mission to enhance the health care services provided to veterans. The contract’s period of performance spans from February 1, 2024, to January 31, 2029, furnishing a multi-year timeline for planned activities under the contract. This extended timeframe is indicative of a sustained collaboration between the VA and the Red Cross, ensuring the continuous availability of required medical services. A notable element in the contract data is the absence of direct monetary obligations or financial outlays at the time of review. This might suggest a preparatory phase where operational parameters and specific directives are yet to translate into financial transactions. Additionally, the contract was procured using non-competitive acquisition methods, denoted by procedures labeled as "ONLY ONE SOURCE - OTHER” under the FAR 6.302-1 exemption, which allows the VA to engage directly with the Red Cross without a competitive bidding process. This strategic decision appears aligned with the specialized capability of the Red Cross in blood management and clinical support services, augmenting the VA's healthcare provision to veterans. The solicitation process, identified with the number 36C260-23-AP-3299, received only a single offer, reinforcing the unique positioning of the Red Cross within this niche service market. The set-aside type was marked as "NONE," meaning there were no specific reservations for small businesses or other preferential categories—a decision likely reflecting the specialized nature of the contract. Contract management elements, such as labor standards and cost or pricing data, emphasize compliance and the fulfillment of federal guidelines. Labor standards are marked as applicable, underscoring adherence to established labor laws or agreements in the delivery of services. Meanwhile, no extraordinary cost or pricing data were required, indicating straightforward pricing mechanisms potentially due to the streamlined and pre-defined nature of the services. The business categories of the American National Red Cross highlight its broad operational purview, including nonprofit and tax-exempt status, as well as capabilities in domestic shelter and manufacturing. This diverse service structure ensures the Red Cross remains a versatile partner, equipped to provide both emergency response and specialized healthcare functions. In terms of geographical considerations, the base of operations for the Red Cross resides in Washington, D.C., yet the contract does not specify a singular place of performance. This could imply a decentralized deployment of services, potentially across multiple sites complementing the VA’s national network. Although detailed financial transactions are not yet recorded within the provided data, the contract lays a foundational framework for anticipated service delivery and resource allocation over its effective period. The intended impact of this contract is to harness the Red Cross’s expertise in blood and organ bank services, streamlining access to therapeutic apheresis for veterans, ultimately contributing positively to veteran healthcare outcomes through this strategic partnership with the VA. Overall, this contract represents a critical investment in the availability of vital medical services for the Department of Veterans Affairs, highlighting the continued commitment to supporting veterans' health needs through reputable and high-standard partnerships with established entities like the American National Red Cross.